ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SLN Silence Therapeutics Plc

535.00
0.00 (0.00%)
06 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 535.00 521.00 524.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Silence Therapeutics Share Discussion Threads

Showing 49126 to 49149 of 53225 messages
Chat Pages: Latest  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1963  1962  Older
DateSubjectAuthorDiscuss
22/10/2012
19:29
I'm still here.enjoying the run to 6p
chicken charlie
22/10/2012
19:21
Happ bithday Gepffmanana..............I guess this BB is so quite as everyone is at your party !!!!
Risen 20% over 2-3 weeks and hardly a comment from some longtermers......that a good sign ? !!

benson384
22/10/2012
14:08
Hi Bill
Yes I am a very happy boy today.....and it's my birthday!!!
Both Kefi and SLN are at least a two year hold for me,but I will be playing with T20s' along the way......GL.

geoffmanana
22/10/2012
13:43
Geoff u must be a very happy boy today. Cheshire Cat? How do u view these two at pres Holder/buyer or dare I say a dirty word seller?
billthebank
22/10/2012
11:19
Bill Kefi is my largest holding.
geoffmanana
22/10/2012
09:58
timeto buy more at a new high??
doc robinson
22/10/2012
08:31
Totally aside but anyone watching KEFI Gold developer miner not producing?
billthebank
22/10/2012
08:29
Eagle Hope the w/e was a good one Played one round on Sunday & apart from 1 birdie the golf was as usual very average. No i son is playing in a national Ho did I do competition Winners get a follow up in Portugal. Pers I def need a lesson to get myself back down to 6 rather than heading North to 12. Sorted the putting yips though this year. Wonder if SLN will ever find a cure for this?!Looking forward to 3.5 this week?!
billthebank
20/10/2012
13:26
Totally agree benson.....GL.
geoffmanana
20/10/2012
13:06
Looking at volumes over last week, where buyers led 3-1 on some days, there seems to be very tightly held bunch of shareholders,who sitting on 6 times your money from 05p fund raiser, must be very confident of this now becoming after 7-8 years a VERY big multibagger.
Stock turn around I think is punters having a ride, take a profit, and move on. I have been adding over past 2-3 months,as I hope the cork is about to pop.
We cant be far away from updates and maybe new licensing deals, stage payments etc. Whatever this stock now has good feel about it.
6 times your money in a few months is very tempting, and the fact there are no serious sellers tells me a lot.
Happy days..................

benson384
20/10/2012
09:02
news this week ???
doc robinson
20/10/2012
09:00
Hope the golf went well Eagle.You must be very proud of the little eaglet,and it's great that she want's to play with the "old man".
I play off 17.6 and my two boys play off six and fourteen....so I have the same problem,but what a wonderful problem!
Glorious morning here in Norfolk.The wife has just gone to play nine holes down the club,and I am about to trim the ivy at the front of the house.....such is life!
Good to see SLN moving in the right direction,and with a good management team behind them....at long last.
I see massive upside from here and I'm adding,when possible, on weakness.
Have you averaged down Eagle?
It could be a good time to do it my friend.....funds permitting of course.
Take care.....Geoff

geoffmanana
19/10/2012
21:10
Ditto Bill!

Agree with everything you said there. I love a fairly quiet, but slow gain northwards.

Off to golf again now and bill my handicap is to poor to tell anyone about at the moment (let's just say it was at 17 when in the UK 5 years ago and now it's a long way from that now!). Little miss eagle who has just turned 17, is only 1 shot worse than me and regularly beats me. Still it's always a great start to the weekend, have fun all.

Eag

ukeagle2aus
19/10/2012
20:25
No idea what b/w is saying as on filter Adds no value to this board. What I feel is there are too many strong buyers around for SLN not to rise & high. They have more info than we will ever be privvy to so let's just enjoy the ride & look forward to the success of RNAi on a co which is still way undervalued when measured against its peers
billthebank
19/10/2012
15:17
Am I mad or is Buywell talking about non-Silence matters and when he talks about Silence he's negative.I cant work here whilst he lives.
amiright
19/10/2012
13:11
Chartwise it has hit resistance
buywell2
19/10/2012
13:04
Quiet on here isn't it?
Just how I like it.....with the share price creeping up.....lovely!

geoffmanana
18/10/2012
22:49
Agree Bill.
geoffmanana
18/10/2012
20:28
I have to admit I can no longer resist the urge . can't see anything stopping this reaching 4p in fairly short time There seems to be buyers around that are pushing the share price onwards & upwards with their presence. GLABs
billthebank
18/10/2012
17:38
good finish !!!
doc robinson
18/10/2012
16:37
Good luck cc.
Yes they look to be on an upward spiral.....fingers crossed.

geoffmanana
18/10/2012
15:28
Geoff
Bought another 300000 to daythe share price looks fairly strong. Famous last words

chicken charlie
18/10/2012
15:26
Same sector but profit making

Note the 'deal' word here in the 2nd para and 2nd to last para





GEN News Highlights : Oct 16, 2012

Sigma Divisions Establish Screening Technology DealsSigma Life Science's Sigma Advanced Genetic Engineering (SAGE) Labs, and Ekam Imaging are teaming up to develop a suite of preclinical services that will combine SAGE's rat models of neurological disorders and Ekam's functional magnetic resonance imaging (fMRI) technology.

Sigma Life Sciences separately announced a deal with ADME/tox services firm Cyprotex, through which the latter will be able to offer its clients knockout transporter screening services utilizing Sigma's CompoZrĀ® zinc finger nuclease technology-based drug screening assays.

SAGE Labs' rat models have been engineered to reflect patient-relevant mutations and exhibit relevant phenotypes. Through the collaboration with Ekam the models will be studied using Ekam's fMRI technology, which can be used to provide detailed maps of a conscious animal's brain activity, unlike other fMRI studies that require anesthetized, unconscious animals, the firms claim. "Probing the brain functions of a conscious animals...produces data that is much more representative of a potential therapy's effect on human processes," comments Mark Nedelman, president and CEO at Ekam.

Sigma and Ekam plan to launch services based on SAGE Labs' neuroscience rat models in early 2013. Ekam is already using its technology to produce a detailed map of neural activity in SAGE Lab's Pink1 gene knockout rat, which has been generated for the Michael J. Fox Foundation to model Parkinson's disease, and exhibits delayed-onset motor deficits that mimic those of Parkinson's disease in humans.

The license agreement between Cyprotex and Sigma represents the first nonexclusive deal signed by the latter for the CompoZr-based knockout transporter cell assay technology. "These novel assays are key products of our highly predictive suite of engineered cell lines and transgenic animal models," remarks Paul Brooks, Ph.D., market segment manager for Sigma Life Sciences.

Cyprotex says the single and double functional knockout transporter services will allow it to offer clients specific, mechanistic assays to investigate the interaction of test compounds with MDR1 (P-gp), BCRP, and MRP2 transporters, without the use of chemical inhibitors that can interact with multiple transporters and produce an ambiguous representation of potential drug-drug interactions.





Sigma is a $8.9 BILLION Mkt Cap company

They have chosen Cyprotex as the first licencee of their new Transporter Technology which the FDA has recently been getting more UP on re testing requirements ..... says a lot methinks

buywell2
18/10/2012
10:04
Going on another little run.....
geoffmanana
Chat Pages: Latest  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1963  1962  Older

Your Recent History

Delayed Upgrade Clock